The literature suggests that the FoxP3:CD3 ratio in the tumor matrix, as well as expression levels of IL-12 and IL-17, is markedly correlated with post-operative recurrence in early lung adenocarcinoma (22–24). This evidence concerns the gene FOXP3 and lung adenocarcinoma.